Functional DNA demethylation is accompanied by chromatin accessibility

Nucleic Acids Research

Volumn 41, Issue 7, 2013, Pages 3973-3985

  Pandiyan, Kurinji ^a,b,c,d   You, Jueng Soo ^a,b   Yang, Xiaojing ^a,b   Dai, Chao ^e   Zhou, Xianghong J ^e   Baylin, Stephen B ^c   Jones, Peter A ^a,b   Liang, Gangning ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Program in Human Genetics   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 20' DEOXYCYTIDINE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE INHIBITOR; HISTONE DEACETYLASE; UNCLASSIFIED DRUG; VORINOSTAT;

ARTICLE; CANCER CELL; CANCER INHIBITION; CHROMATIN; COLORECTAL CANCER; CONTROLLED STUDY; DNA DEMETHYLATION; DNA METABOLISM; DNA METHYLATION; EMBRYO; EPIGENETICS; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION;

AZACITIDINE; CELL LINE, TUMOR; CHROMATIN; DNA METHYLATION; GENES, TUMOR SUPPRESSOR; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; PROMOTER REGIONS, GENETIC;

EID: 84876585121     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt077     Document Type: Article

References (49)

1. Jones, P.A. and Baylin, S.B. (2007) The epigenomics of cancer. Cell, 128, 683-692. (Pubitemid 46273572)
2. Sandoval, J. and Esteller, M. (2012) Cancer epigenomics: beyond genomics. Curr. Opin. Genet. Dev., 22, 50-55.
3. Baylin, S.B. and Jones, P.A. (2011) A decade of exploring the cancer epigenome-biological and translational implications. Nat. Rev. Cancer, 11, 726-734.
4. You, J.S and Jones, P.A. (2012) Cancer genetics and epigenetics: two sides of the same coin Cancer Cell, 22, 9-20.
5. Andreu-Vieyra, C.V. and Liang, G. (2012) Nucleosome occupancy and gene regulation during tumorigenesis. Adv. Exp. Med. Biol., 754, 109-134.
6. Schones, D.E., Cui, K., Cuddapah, S., Roh, T.Y., Barski, A., Wang, Z., Wei, G. and Zhao, K. (2008) Dynamic regulation of nucleosome positioning in the human genome. Cell, 132, 887-898. (Pubitemid 351312809)
7. Bai, L. and Morozov, A.V. (2010) Gene regulation by nucleosome positioning. Trends Genet., 26, 476-483.
8. Bell, O., Tiwari, V.K., Thoma, N.H. and Schubeler, D. (2011) Determinants and dynamics of genome accessibility. Nat. Rev. Genet., 12, 554-564.
9. Segal, E. and Widom, J. (2009) What controls nucleosome positions Trends Genet., 25, 335-343.
10. Lin, J.C., Jeong, S., Liang, G., Takai, D., Fatemi, M., Tsai, Y.C., Egger, G., Gal-Yam, E.N. and Jones, P.A. (2007) Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell, 12, 432-444. (Pubitemid 350046405)
11. Hinshelwood, R.A., Melki, J.R., Huschtscha, L.I., Paul, C., Song, J.Z., Stirzaker, C., Reddel, R.R. and Clark, S.J. (2009) Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hum. Mol. Genet., 18, 3098-3109.
12. Wilson, B.G. and Roberts, C.W.M. (2011) SWI/SNF nucleosome remodellers and cancer. Nat. Rev. Cancer, 11, 481-492.
13. Rodriguez-Paredes, M. and Esteller, M. (2011) Cancer epigenetics reaches mainstream oncology. Nat. Med., 17, 330-339.
14. Dawson, M.A. and Kouzarides, T. (2012) Cancer epigenetics: from mechanism to therapy. Cell, 150, 12-27.
15. List, A.F., Vardiman, J., Issa, J.P. and DeWitte, T.M. (2004) Myelodysplastic syndromes. Hematology Am. Soc. Hematol. Educ. Program, 297-317.
16. Griffiths, E.A. and Gore, S.D. (2013) Epigenetic therapies in MDS and AML. Adv. Exp. Med. Biol., 754, 253-283.
17. Tsai, H.C., Li, H., Van Neste, L., Cai, Y., Robert, C., Rassool, F.V., Shin, J.J., Harbom, K.M., Beaty, R., Pappou, E. et al. (2012) Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell, 21, 430-446.
18. Juergens, R.A., Wrangle, J., Vendetti, F.P., Murphy, S.C., Zhao, M., Coleman, B., Sebree, R., Rodgers, K., Hooker, C.M., Franco, N. et al. (2011) Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov., 1, 598-607.
19. Garcia-Manero, G. (2008) Demethylating agents in myeloid malignancies. Curr. Opin. Oncol., 20, 705-710.
20. Matei, D.E. and Nephew, K.P. (2010) Epigenetic therapies for chemoresensitization of epithelial ovarian cancer. Gynecol. Oncol., 116, 195-201.
21. Blumenschein, G.R. Jr, Kies, M.S., Papadimitrakopoulou, V.A., Lu, C., Kumar, A.J., Ricker, J.L., Chiao, J.H., Chen, C. and Frankel, S.R. (2008) Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer. Invest. New Drugs, 26, 81-87.
22. Kalari, S. and Pfeifer, G.P. (2010) Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv. Genet., 70, 277-308.
23. Gal-Yam, E.N., Jeong, S., Tanay, A., Egger, G., Lee, A.S. and Jones, P.A. (2006) Constitutive nucleosome depletion and ordered factor assembly at the GRP78 promoter revealed by single molecule footprinting. PLoS Genet., 2, e160.
24. Noushmehr, H., Weisenberger, D.J., Diefes, K., Phillips, H.S., Pujara, K., Berman, B.P., Pan, F., Pelloski, C.E., Sulman, E.P., Bhat, K.P. et al. (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell, 17, 510-522.
25. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, C., Singh, H. and Glass, C.K. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell, 38, 576-589.
26. Sandoval, J., Heyn, H., Moran, S., Serra-Musach, J., Pujana, M.A., Bibikova, M. and Esteller, M. (2011) Validation of a DNA methylation microarray for 450, 000 CpG sites in the human genome. Epigenetics, 6, 692-702.
27. Du, P., Zhang, X., Huang, C.C., Jafari, N., Kibbe, W.A., Hou, L. and Lin, S.M. (2010) Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics, 11, 587.
28. Ben-Porath, I., Thomson, M.W., Carey, V.J., Ge, R., Bell, G.W., Regev, A. and Weinberg, R.A. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet., 40, 499-507. (Pubitemid 351601215)
29. Gal-Yam, E.N., Egger, G., Iniguez, L., Holster, H., Einarsson, S., Zhang, X., Lin, J.C., Liang, G., Jones, P.A. and Tanay, A. (2008) Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc. Natl Acad. Sci. USA, 105, 12979-12984.
30. Kondo, Y., Shen, L., Cheng, A.S., Ahmed, S., Boumber, Y., Charo, C., Yamochi, T., Urano, T., Furukawa, K., Kwabi-Addo, B. et al. (2008) Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet., 40, 741-750. (Pubitemid 351748874)
31. Larson, P.S., Schlechter, B.L., King, C.L., Yang, Q., Glass, C.N., Mack, C., Pistey, R., de Las Morenas, A. and Rosenberg, C.L. (2008) CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer. BMC Cancer, 8, 68.
32. Park, K., Kim, K., Rho, S.B., Choi, K., Kim, D., Oh, S.H., Park, J., Lee, S.H. and Lee, J.H. (2005) Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis. Cancer Res., 65, 749-757. (Pubitemid 40216432)
33. Mellman, I., Coukos, G. and Dranoff, G. (2011) Cancer immunotherapy comes of age. Nature, 480, 480-489.
34. Rhee, I., Bachman, K.E., Park, B.H., Jair, K.W., Yen, R.W., Schuebel, K.E., Cui, H., Feinberg, A.P., Lengauer, C., Kinzler, K.W. et al. (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature, 416, 552-556. (Pubitemid 34288859)
35. Egger, G., Jeong, S., Escobar, S.G., Cortez, C.C., Li, T.W., Saito, Y., Yoo, C.B., Jones, P.A. and Liang, G. (2006) Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival. Proc. Natl Acad. Sci. USA, 103, 14080-14085. (Pubitemid 44452983)
36. Yi, J.M., Tsai, H.C., Glockner, S.C., Lin, S., Ohm, J.E., Easwaran, H., James, C.D., Costello, J.F., Riggins, G., Eberhart, C.G. et al. (2008) Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res., 68, 8094-8103.
37. Hellebrekers, D.M., Lentjes, M.H., van den Bosch, S.M., Melotte, V., Wouters, K.A., Daenen, K.L., Smits, K.M., Akiyama, Y., Yuasa, Y., Sanduleanu, S. et al. (2009) GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin. Cancer Res., 15, 3990-3997.
38. Jin, H.O., Seo, S.K., Kim, Y.S., Woo, S.H., Lee, K.H., Yi, J.Y., Lee, S.J., Choe, T.B., Lee, J.H., An, S. et al. (2011) TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1. Oncogene, 30, 3792-3801.
39. Yu, W., Lin, Z., Pastor, D.M., Hegarty, J.P., Chen, X., Kelly, A.A., Wang, Y., Poritz, L.S. and Koltun, W.A. (2010) Genes regulated by Nkx2-3 in sporadic and inflammatory bowel disease-associated colorectal cancer cell lines. Dig. Dis. Sci., 55, 3171-3180.
40. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S. et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA, 102, 15545-15550. (Pubitemid 41528093)
41. Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B.E. et al. (2007) Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet., 39, 232-236. (Pubitemid 46184355)
42. Schuebel, K.E., Chen, W., Cope, L., Glockner, S.C., Suzuki, H., Yi, J.M., Chan, T.A., Van Neste, L., Van Criekinge, W., van den Bosch, S. et al. (2007) Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet., 3, 1709-1723. (Pubitemid 47510263)
43. Gruffat, H., Manet, E. and Sergeant, A. (2002) MEF2-mediated recruitment of class II HDAC at the EBV immediate early gene BZLF1 links latency and chromatin remodeling. EMBO Rep., 3, 141-146. (Pubitemid 34213491)
44. Chokas, A.L., Trivedi, C.M., Lu, M.M., Tucker, P.W., Li, S., Epstein, J.A. and Morrisey, E.E. (2010) Foxp1/2/4-NuRD interactions regulate gene expression and epithelial injury response in the lung via regulation of interleukin-6. J. Biol. Chem., 285, 13304-13313.
45. Chung, Y.M., Park, S.H., Tsai, W.B., Wang, S.Y., Ikeda, M.A., Berek, J.S., Chen, D.J. and Hu, M.C. (2012) FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage. Nat. Commun., 3, 1000.
46. Madison, B.B., McKenna, L.B., Dolson, D., Epstein, D.J. and Kaestner, K.H. (2009) FoxF1 and FoxL1 link hedgehog signaling and the control of epithelial proliferation in the developing stomach and intestine. J. Biol. Chem., 284, 5936-5944.
47. Yang, X., Noushmehr, H., Han, H., Andreu-Vieyra, C., Liang, G. and Jones, P.A. (2012) Gene reactivation by 5-aza-20-deoxycytidine-induced demethylation requires SRCAP-mediated H2A.Z insertion to establish nucleosome depleted regions. PLoS Genet., 8, e1002604.
48. Cameron, E.E., Bachman, K.E., Myohanen, S., Herman, J.G. and Baylin, S.B. (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet., 21, 103-107. (Pubitemid 29036293)
49. Oki, Y., Aoki, E. and Issa, J.P. (2007) Decitabine-bedside to bench. Crit. Rev. Oncol. Hematol., 61, 140-152. (Pubitemid 46073782)